tag:blogger.com,1999:blog-36634196.post3326649904158470778..comments2023-10-09T11:33:37.853-05:00Comments on The IN VIVO Blog: Roche/Genentech: When Independence Costs Too MuchChris Morrisonhttp://www.blogger.com/profile/04075266444951558159noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-36634196.post-16276724303164232972008-07-22T21:53:00.000-05:002008-07-22T21:53:00.000-05:00As they mention Syntex (Roche Palo Alto) in the st...As they mention Syntex (Roche Palo Alto) in the story, it would seem to be relevant. Syntex went from 5,000 employees to 0 in only 12 years (while Roche made money the whole time and mismanaged things from afar)! The author is right, Roche is a bank and they shouldn't be allowed to even utter the word "innovation". Watch out Genentech!Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-79590833881748983502008-07-22T18:44:00.000-05:002008-07-22T18:44:00.000-05:00Maybe because unlike you, we don't work there.Maybe because unlike you, we don't work there.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-65672528863747942682008-07-22T16:50:00.000-05:002008-07-22T16:50:00.000-05:00I am surprised no one is talking about the effects...I am surprised no one is talking about the effects of the merger on the Roche Palo Alto campus.Anonymousnoreply@blogger.com